Community-based access to oral antiviral treatments for COVID-19 in Australia

Elizabeth Sturgiss; Nick Simpson; Lauren Ball; Sally Hall Dykgraaf; Paul Kelly; Michael Kidd

doi:10.31128/AJGP-01-23-6673

Community-based access to oral antiviral treatments for COVID-19 in Australia

Elizabeth Sturgiss^*
, Nick Simpson
, Lauren Ball
, Sally Hall Dykgraaf
, Paul Kelly
, Michael Kidd

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

4 Citations (Scopus)

Abstract

Background The availability of oral antivirals for SARS-CoV-2 infection reduces the risk of severe, acute illness in people at higher risk for death and hospitalisation.

Objective The process for antiviral prescription and dispensing in Australia is outlined using nationwide data.

Discussion Australia has focused on providing rapid access to antivirals to high-risk people in the community via general practices and community pharmacies. Although the introduction of oral antiviral treatments is an important part of the response to the COVID-19 pandemic, vaccination remains the most effective way of mitigating the risk of developing severe complications of COVID-19, including hospitalisation and death.

Original language	English
Pages (from-to)	409-412
Number of pages	4
Journal	Australian Journal of General Practice
Volume	52
Issue number	6
DOIs	https://doi.org/10.31128/AJGP-01-23-6673
Publication status	Published - 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.31128/AJGP-01-23-6673

Cite this

@article{2404b58521f247d5a322cf637682cee8,

title = "Community-based access to oral antiviral treatments for COVID-19 in Australia",

abstract = "Background The availability of oral antivirals for SARS-CoV-2 infection reduces the risk of severe, acute illness in people at higher risk for death and hospitalisation. Objective The process for antiviral prescription and dispensing in Australia is outlined using nationwide data. Discussion Australia has focused on providing rapid access to antivirals to high-risk people in the community via general practices and community pharmacies. Although the introduction of oral antiviral treatments is an important part of the response to the COVID-19 pandemic, vaccination remains the most effective way of mitigating the risk of developing severe complications of COVID-19, including hospitalisation and death.",

author = "Elizabeth Sturgiss and Nick Simpson and Lauren Ball and Dykgraaf, \{Sally Hall\} and Paul Kelly and Michael Kidd",

note = "Publisher Copyright: {\textcopyright} The Royal Australian College of General Practitioners 2023",

year = "2023",

doi = "10.31128/AJGP-01-23-6673",

language = "English",

volume = "52",

pages = "409--412",

journal = "Australian Journal of General Practice",

issn = "2208-794X",

publisher = "Royal Australian College of General Practitioners",

number = "6",

}

TY - JOUR

T1 - Community-based access to oral antiviral treatments for COVID-19 in Australia

AU - Sturgiss, Elizabeth

AU - Simpson, Nick

AU - Ball, Lauren

AU - Dykgraaf, Sally Hall

AU - Kelly, Paul

AU - Kidd, Michael

PY - 2023

Y1 - 2023

N2 - Background The availability of oral antivirals for SARS-CoV-2 infection reduces the risk of severe, acute illness in people at higher risk for death and hospitalisation. Objective The process for antiviral prescription and dispensing in Australia is outlined using nationwide data. Discussion Australia has focused on providing rapid access to antivirals to high-risk people in the community via general practices and community pharmacies. Although the introduction of oral antiviral treatments is an important part of the response to the COVID-19 pandemic, vaccination remains the most effective way of mitigating the risk of developing severe complications of COVID-19, including hospitalisation and death.

AB - Background The availability of oral antivirals for SARS-CoV-2 infection reduces the risk of severe, acute illness in people at higher risk for death and hospitalisation. Objective The process for antiviral prescription and dispensing in Australia is outlined using nationwide data. Discussion Australia has focused on providing rapid access to antivirals to high-risk people in the community via general practices and community pharmacies. Although the introduction of oral antiviral treatments is an important part of the response to the COVID-19 pandemic, vaccination remains the most effective way of mitigating the risk of developing severe complications of COVID-19, including hospitalisation and death.

UR - https://www.scopus.com/pages/publications/85161638516

U2 - 10.31128/AJGP-01-23-6673

DO - 10.31128/AJGP-01-23-6673

M3 - Article

C2 - 37291821

AN - SCOPUS:85161638516

SN - 2208-794X

VL - 52

SP - 409

EP - 412

JO - Australian Journal of General Practice

JF - Australian Journal of General Practice

IS - 6

ER -

Community-based access to oral antiviral treatments for COVID-19 in Australia

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this